NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the…
Pieces will deploy new conversational AI at MetroHealth that will interact directly with cancer patients and leverage pioneering human oversight…
COLLINSVILLE, Conn., Oct. 29, 2024 /PRNewswire/ -- Emry Health's commitment to create better, lower-cost benefit experiences for members is now…
It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / October…
Jupiter, Florida--(Newsfile Corp. - October 29, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate…
Company will present results from the ReSPECT-LM Phase 1 clinical trial of Rhenium (186Re) Obisbemeda for leptomeningeal metastases (LM) and…
The pricing announcement from the Center for Medicare Services became effective on October 1, 2024, and allows BioStem to begin…
NEW YORK and LONDON and SAO PAOLO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Claritas NucMed Tech Brazil S.A. (“Claritas NucMed…
Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29,…
MINNEAPOLIS, Oct. 28, 2024 /PRNewswire/ -- Alimetry has raised an oversubscribed US $18m A2 financing round to commercialise its wearable gut…